Growing diagnostics PHASE Scientific is a high-growth biotechnology company focused on early disease detection with proprietary PHASIFY technology, presenting opportunities to partner on diagnostic tool integration, lab services, and expanded screening programs for cancer and infectious diseases.

Global footprint Headquartered in Hong Kong with offices in Southern California and the Greater Bay Area positions PHASE for regional market access across Asia-Pacific and North America, suggesting sales potential through cross-border distribution, local regulatory support, and regional partnerships.

At home tests INDICAID at-home rapid tests indicate demand for convenient, consumer-facing diagnostics and potential channel growth through pharmacies, online retailers, or employer health programs, expanding reach beyond traditional clinical labs.

Strategic funding Recent US$34 million Series A funding signals investor confidence and capacity for scale, enabling aggressive sales expansion, new product launches, and expanded commercialization of PHASIFY powered tools to capture larger market share.

Laboratory services PHASE lab offers specialized diagnostic services for cancer and infectious diseases powered by PHASIFY, creating opportunities for enterprise collaborations, contract research, and integrated testing programs with health systems and biotech partners.